NPI registry status
Active
2026 NPPES data Ophthalmology Physician NPI 1659463347 M.D.
Verify on CMS → Jeremy Chess, M.D.
Ophthalmology Physician in Bronx, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,388 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 598 beneficiaries · Ophthalmology Physician avg: 1K
MIPS score
0/100
▼ 84 pts below national avg 83.5 · Penalty band
What the federal data shows
Jeremy Chess, M.D. reported a CMS MIPS final score of 0/100 - below the 83.5 national average - and filed 2,714 Medicare Part D claims in 2024.
- 0/100
- MIPS score · -83 vs avg
- 3K
- Part D claims, 2024
- Likely
- board-certified (heuristic)
- ≥0th
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Jeremy Chess, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1659463347), first enumerated 09/29/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,714 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 0/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Jeremy Chess, M.D.'s individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1659463347 · Ophthalmology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-LOW · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1659463347
- ENUM-LEGACY 2006
- TAX-MID 22K Ophthalmology Physician
- MIPS-LOW 0/100
- RX-MID 2,714
- BOOK-LIGHT 1,746 in New York
- PHOTO-FINISH Ednan Ahmed, M.D. · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Chess · this pro… 0
Chess · this provider
0 MIPS pts
- Barbara Arnold, … 0
Barbara Arnold, MD
0 MIPS pts
- Ednan Ahmed, M.D… 0
Ednan Ahmed, M.D.
0 MIPS pts
- Payam Amini, M.D… 0
Payam Amini, M.D
0 MIPS pts
- Bertrand Anz, MD… 0
Bertrand Anz, MD
0 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Jeremy Chess, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
0 ≥ 0th percentile 0% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Jeremy Chess, M.D. sits
This provider among ophthalmology physician peers
Across the 8,767 ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Jeremy Chess, M.D. writes more Part D claims than 83% of them and scores higher on MIPS quality than 0% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one ophthalmology physician peer from a representative sample of 60; the gold marker is Jeremy Chess, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Jeremy Chess, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Jeremy Chess, M.D.?
Below national averagePrimary specialty
Ophthalmology Physician
Medicare Part D claims
2,714 82% vs specialty avg
MIPS final score
0/100 83.5 pts vs avg
Specialty distribution in New York
How Ophthalmology Physician compares to other specialties among New York providers
Medicare quality performance, MIPS
Jeremy Chess, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 0/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1659463347 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 09/29/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
0
Final Score
Measured-score avg: 83.5
0
Quality
Reporting: Individual
Hospital and facility affiliations
Facilities where Jeremy Chess, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Retina Group PC
Bronx, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Jeremy Chess, M.D.. To verify Jeremy Chess, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
2,714
Total Claims
$330K
Total Drug Cost
598
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,486.967
- Total Day Supply
- 129,381
- Generic Drug Cost
- $43K
Patient Demographics
- Average Patient Age
- 75.4 years
- Avg HCC Risk Score
- 1.89
- Gender Split
- 56% female / 44% male
- Age Distribution
- <65: 49, 65-74: 240, 75-84: 213, 85+: 96
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Jeremy Chess, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Latanoprost
Latanoprost
365 claims
- Dorzolamide Hcl
Dorzolamide Hcl
307 claims
- Brimonidine Tartrate
Brimonidine Tartrate
200 claims
- Timolol Maleate
Timolol Maleate
197 claims
- Prednisolone Acetate
Prednisolone Acetate
194 claims
- Combigan 120
Combigan
120 claims
- Ketorolac Trometha… 107
Ketorolac Tromethamine
107 claims
- Lumigan 89
Lumigan
89 claims
| Drug | Claims |
|---|---|
| Latanoprost | 365 |
| Dorzolamide Hcl | 307 |
| Brimonidine Tartrate | 200 |
| Timolol Maleate | 197 |
| Prednisolone Acetate | 194 |
| Combigan Brimonidine Tartrate/Timolol | 120 |
| Ketorolac Tromethamine | 107 |
| Lumigan Bimatoprost | 89 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 87 |
| Restasis Cyclosporine | 87 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Jeremy Chess, M.D. fits within the Ophthalmology Physician landscape nationally.
22,388
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,490
Avg Claims per Provider
Jeremy Chess, M.D.'s 2,714 claims are above the specialty average of 1,490.
Nationwide Ophthalmology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Chess, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (0 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Ophthalmology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Chess.
One of 1,746 Ophthalmology Physician providers enrolled in New York, 5 are shown here.
Dr. Aliaa Abdelhakim Hamed
M.D., PH.D.
New York, NY
Dr. Majida Abdul Gaffar
M.D.
Hawthorne, NY
Dr. David H Abramson
MD
New York, NY
Dr. Frank Accardi
MD
New York, NY
Dr. Jacob Ackerman
MD
Brooklyn, NY
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Jeremy Chess, M.D.'s specialty? ▼
Jeremy Chess, M.D. specializes in Ophthalmology Physician and practices in Bronx, New York. Credentials: M.D..
How much does Jeremy Chess, M.D. prescribe under Medicare Part D? ▼
In 2024, Jeremy Chess, M.D. wrote 2,714 Medicare Part D claims totaling $330K in drug costs for 598 beneficiaries.
What is Jeremy Chess, M.D.'s Medicare quality score? ▼
Jeremy Chess, M.D. has a CMS MIPS Final Score of 0/100 (Quality: 0). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Jeremy Chess, M.D. located? ▼
Jeremy Chess, M.D. is located at 2221 BOSTON RD, Bronx, NY, 10467. Phone: (718) 798-3030.
What is Jeremy Chess, M.D.'s NPI number? ▼
Jeremy Chess, M.D.'s National Provider Identifier (NPI) is 1659463347, issued on 09/29/2006.
How many Ophthalmology Physician providers are there in the US? ▼
There are 22,388 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,490 Medicare Part D claims per year.
What drugs does Jeremy Chess, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Jeremy Chess, M.D.'s most frequently prescribed drugs include Latanoprost, Dorzolamide Hcl, Brimonidine Tartrate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Jeremy Chess, M.D. accept Medicare? ▼
Jeremy Chess, M.D. appears in CMS Medicare data with 2,714 Part D claims and 598 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Jeremy Chess, M.D.'s credentials? ▼
Jeremy Chess, M.D.'s NPI is 1659463347 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.